Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,964 public trials 1,826 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Recruiting

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

NCT03460977

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Disease Attributes, +23 more
Locations
  • Banner-University Medical Center Tucson Tucson, Arizona, United States
  • The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Arizona Urology Specialists, PLLC Tucson, Arizona, United States
View all 83 locations
View Trial Details
Recruiting

A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL

NCT05748171

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • St. Anna Kinderspital Vienna, Austria
  • Cliniques universitaires Saint-Luc Brussels, Bruxelles-capitale, Région de, Belgium
  • UZ Gent Ghent, Oost-vlaanderen, Belgium
  • UZ Leuven Leuven, Vlaams-brabant, Belgium
View all 68 locations
View Trial Details
Recruiting

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

NCT07509151

Conditions
Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Research Site Adelaide, Australia
  • Research Site Fitzroy, Australia
  • Research Site Heidelberg, Australia
  • Research Site Nedlands, Australia
View all 30 locations
View Trial Details
Recruiting

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

NCT07075185

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease, +24 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford University Palo Alto, California, United States
  • UCSF San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Recruiting

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

NCT04588922

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
Locations
  • O'Neal Comprehensive Cancer Center, University of Alabama Birmingham, Alabama, United States
  • City of Hope - Phoenix Goodyear, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 26 locations
View Trial Details

Related conditions